Clinical Trial: Trial of Autologous Mesenchymal Stem Cells in Patients With Multiple System Atrophy
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Double-blind Placebo-controlled Randomized Clinical Trial of Autologous Mesenchymal Stem Cells in Patients With Multiple System Atrophy
Brief Summary: This study is based on positive results in open label trial of mesenchymal stem cells therapy in patients with Multiple System Atrophy (MSA).
Detailed Summary:
Sponsor: Yonsei University
Current Primary Outcome: Scores on unified MSA rating scale [ Time Frame: one month ]
Original Primary Outcome: Unified MSA rating scale by every month and every year
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Yonsei University
Dates:
Date Received: May 26, 2009
Date Started: May 2008
Date Completion:
Last Updated: August 2, 2011
Last Verified: July 2011